Recent Peer Reviewed Publications

• 1. Basu M
  2. Fucile C
  3. Piepenbrink M
  4. Bunce C
  5. Man LX
  6. Liesveld J
  7. Rosenberg A
  8. Keefer M
  9. Kobie JJ
  Mixed Origins: HIV gp120-specific memory develops from pre-existing memory and naïve B cells following vaccination in humans.; AIDS research and human retroviruses. 2023 Feb 10.
• 1. Mena Lora AJ
  2. Long JE
  3. Huang Y
  4. Baden LR
  5. El Sahly HM
  6. Follmann D
  7. Goepfert P
  8. Gray G
  9. Grinsztejn B
  10. Kotloff K
  11. Rouphael N
  12. Sobieszczyk M
  13. Walsh SR
  14. Andriesen J
  15. Shah KA
  16. Zhang Y
  17. Gilbert P
  18. Janes H
  19. Gay CL
  20. Falsey AR
  21. Tripp RL
  22. Gorman RL
  23. Tong T
  24. Marovich M
  25. Neuzil K
  26. Corey L
  27. Kublin JG
  Rapid Development of an Integrated Network Infrastructure to Conduct Phase 3 COVID-19 Vaccine Trials.; JAMA network open; Vol 6(1), pp. e2251974. 2023 Jan 03.
• 1. Huang Y
  2. Zhang Y
  3. Seaton KE
  4. De Rosa S
  5. Heptinstall J
  6. Carpp LN
  7. Randhawa AK
  8. McKinnon LR
  9. McLaren P
  10. Viegas E
  11. Gray GE
  12. Churchyard G
  13. Buchbinder SP
  14. Edupuganti S
  15. Bekker LG
  16. Keefer MC
  17. Hosseinipour MC
  18. Goepfert PA
  19. Cohen KW
  20. Williamson BD
  21. McElrath MJ
  22. Tomaras GD
  23. Thakar J
  24. Kobie JJ
  Baseline host determinants of robust human HIV-1 vaccine-induced immune responses: A meta-analysis of 26 vaccine regimens.; EBioMedicine; Vol 84, pp. 104271. 2022 Sep 27.
• 1. Branche AR
  2. Saiman L
  3. Walsh EE
  4. Falsey AR
  5. Jia H
  6. Barrett A
  7. Alba L
  8. Phillips M
  9. Finelli L
  Change in functional status associated with respiratory syncytial virus infection in hospitalized older adults.; Influenza and other respiratory viruses. 2022 Sep 07.
• 1. Benedict K
  2. Gold JAW
  3. Jenkins EN
  4. Roland J
  5. Barter D
  6. Czaja CA
  7. Johnston H
  8. Clogher P
  9. Farley MM
  10. Revis A
  11. Harrison LH
  12. Tourdot L
  13. Davis SS
  14. Phipps EC
  15. Felsen CB
  16. Tesini BL
  17. Escutia G
  18. Pierce R
  19. Zhang A
  20. Schaffner W
  21. Lyman M
  Low Sensitivity of International Classification of Diseases, Tenth Revision Coding for Culture-Confirmed Candidemia Cases in an Active Surveillance System: United States, 2019-2020.; Open forum infectious diseases; Vol 9(9), pp. ofac461. 2022 Sep 07.
• 1. Branche AR
  2. Rouphael NG
  3. Diemert DJ
  4. Falsey AR
  5. Losada C
  6. Baden LR
  7. Frey SE
  8. Whitaker JA
  9. Little SJ
  10. Anderson EJ
  11. Walter EB
  12. Novak RM
  13. Rupp R
  14. Jackson LA
  15. Babu TM
  16. Kottkamp AC
  17. Luetkemeyer AF
  18. Immergluck LC
  19. Presti RM
  20. Bäcker M
  21. Winokur PL
  22. Mahgoub SM
  23. Goepfert PA
  24. Fusco DN
  25. Malkin E
  26. Bethony JM
  27. Walsh EE
  28. Graciaa DS
  29. Samaha H
  30. Sherman AC
  31. Walsh SR
  32. Abate G
  33. Oikonomopoulou Z
  34. El Sahly HM
  35. Martin TCS
  36. Rostad CA
  37. Smith MJ
  38. Ladner BG
  39. Porterfield L
  40. Dunstan M
  41. Wald A
  42. Davis T
  43. Atmar RL
  44. Mulligan MJ
  45. Lyke KE
  46. Posavad CM
  47. Meagher MA
  48. Stephens DS
  49. Neuzil KM
  50. Abebe K
  51. Hill H
  52. Albert J
  53. Lewis TC
  54. Giebeig LA
  55. Eaton A
  56. Netzl A
  57. Wilks SH
  58. Türeli S
  59. Makhene M
  60. Crandon S
  61. Lee M
  62. Nayak SU
  63. Montefiori DC
  64. Makowski M
  65. Smith DJ
  66. Roberts PC
  67. Beigel JH
  SARS-CoV-2 Variant Vaccine Boosters Trial: Preliminary Analyses.; medRxiv : the preprint server for health sciences. 2022 Jul 15.
• 1. Lyke KE
  2. Atmar RL
  3. Islas CD
  4. Posavad CM
  5. Szydlo D
  6. Paul Chourdhury R
  7. Deming ME
  8. Eaton A
  9. Jackson LA
  10. Branche AR
  11. El Sahly HM
  12. Rostad CA
  13. Martin JM
  14. Johnston C
  15. Rupp RE
  16. Mulligan MJ
  17. Brady RC
  18. Frenck RW
  19. Bäcker M
  20. Kottkamp AC
  21. Babu TM
  22. Rajakumar K
  23. Edupuganti S
  24. Dobrzynski D
  25. Coler RN
  26. Archer JI
  27. Crandon S
  28. Zemanek JA
  29. Brown ER
  30. Neuzil KM
  31. Stephens DS
  32. Post DJ
  33. Nayak SU
  34. Suthar MS
  35. Roberts PC
  36. Beigel JH
  37. Montefiori DC
  Rapid decline in vaccine-boosted neutralizing antibodies against SARS-CoV-2 Omicron variant.; Cell reports. Medicine; Vol 3(7), pp. 100679. 2022 Jun 20.
• 1. Wolfe CR
  2. Tomashek KM
  3. Patterson TF
  4. Gomez CA
  5. Marconi VC
  6. Jain MK
  7. Yang OO
  8. Paules CI
  9. Palacios GMR
  10. Grossberg R
  11. Harkins MS
  12. Mularski RA
  13. Erdmann N
  14. Sandkovsky U
  15. Almasri E
  16. Pineda JR
  17. Dretler AW
  18. de Castilla DL
  19. Branche AR
  20. Park PK
  21. Mehta AK
  22. Short WR
  23. McLellan SLF
  24. Kline S
  25. Iovine NM
  26. El Sahly HM
  27. Doernberg SB
  28. Oh MD
  29. Huprikar N
  30. Hohmann E
  31. Kelley CF
  32. Holodniy M
  33. Kim ES
  34. Sweeney DA
  35. Finberg RW
  36. Grimes KA
  37. Maves RC
  38. Ko ER
  39. Engemann JJ
  40. Taylor BS
  41. Ponce PO
  42. Larson L
  43. Melendez DP
  44. Seibert AM
  45. Rouphael NG
  46. Strebe J
  47. Clark JL
  48. Julian KG
  49. de Leon AP
  50. Cardoso A
  51. de Bono S
  52. Atmar RL
  53. Ganesan A
  54. Ferreira JL
  55. Green M
  56. Makowski M
  57. Bonnett T
  58. Beresnev T
  59. Ghazaryan V
  60. Dempsey W
  61. Nayak SU
  62. Dodd LE
  63. Beigel JH
  64. Kalil AC
  Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial.; The Lancet. Respiratory medicine. 2022 May 23.
• 1. Monaco CL
  HIV, AIDS, and the virome: Gut reactions.; Cell host & microbe; Vol 30(4). 2022 Apr 13.
• 1. Drame FN
  2. Urban MA
  3. Inscho RR
  4. Mendoza MD
  5. Hiltunen K
  6. Owens JM
  7. Stone C
  8. Hart-Malloy R
  Best Practices Implementation: Congenital Syphilis Prevention Efforts in Monroe County, New York, 2018.; Sexually transmitted diseases; Vol 49(4). 2022 Apr 01.
• 1. Branche AR
  2. Saiman L
  3. Walsh EE
  4. Falsey AR
  5. Sieling WD
  6. Greendyke W
  7. Peterson DR
  8. Vargas CY
  9. Phillips M
  10. Finelli L
  Incidence of Respiratory Syncytial Virus Infection Among Hospitalized Adults, 2017-2020.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America; Vol 74(6), pp. 1004-1011. 2022 Mar 23.
• 1. Atmar RL
  2. Lyke KE
  3. Deming ME
  4. Jackson LA
  5. Branche AR
  6. El Sahly HM
  7. Rostad CA
  8. Martin JM
  9. Johnston C
  10. Rupp RE
  11. Mulligan MJ
  12. Brady RC
  13. Frenck RW
  14. Bäcker M
  15. Kottkamp AC
  16. Babu TM
  17. Rajakumar K
  18. Edupuganti S
  19. Dobrzynski D
  20. Coler RN
  21. Posavad CM
  22. Archer JI
  23. Crandon S
  24. Nayak SU
  25. Szydlo D
  26. Zemanek JA
  27. Dominguez Islas CP
  28. Brown ER
  29. Suthar MS
  30. McElrath MJ
  31. McDermott AB
  32. O'Connell SE
  33. Montefiori DC
  34. Eaton A
  35. Neuzil KM
  36. Stephens DS
  37. Roberts PC
  38. Beigel JH
  Homologous and Heterologous Covid-19 Booster Vaccinations.; The New England journal of medicine; Vol 386(11). 2022 Mar 17.
• 1. Seagle EE
  2. Jackson BR
  3. Lockhart SR
  4. Georgacopoulos O
  5. Nunnally NS
  6. Roland J
  7. Barter DM
  8. Johnston HL
  9. Czaja CA
  10. Kayalioglu H
  11. Clogher P
  12. Revis A
  13. Farley MM
  14. Harrison LH
  15. Davis SS
  16. Phipps EC
  17. Tesini BL
  18. Schaffner W
  19. Markus TM
  20. Lyman MM
  The Landscape of Candidemia During the Coronavirus Disease 2019 (COVID-19) Pandemic.; Clinical infectious diseases : an official publication of the Infectious Diseases Society of America; Vol 74(5). 2022 Mar 09.
• 1. Madere FS
  2. Sohn M
  3. Winbush AK
  4. Barr B
  5. Grier A
  6. Palumbo C
  7. Java J
  8. Meiring T
  9. Williamson AL
  10. Bekker LG
  11. Adler DH
  12. Monaco CL
  Transkingdom Analysis of the Female Reproductive Tract Reveals Bacteriophages form Communities.; Viruses; Vol 14(2). 2022 Feb 19.
• 1. Anderson LJ
  2. Walsh EE
  The Challenge of Respiratory Syncytial Virus Human Challenge Studies.; The New England journal of medicine; Vol 386(7). 2022 Feb 17.